Our paper on cancer screening in myositis. Thanks to Sinan and @LatikaGupta_ Check out our approach for high, moderate, and low risk for cancer in myositis. Not everyone needs extensive screening, but high-risk patients need careful monitoring. https://t.co/KHrI205GOh
¿Te perdiste nuesto simposim de #EPID#autoinmunes?
No problem. Aqui tienes las grabaciones
01. Inauguración y casos clínicos: https://t.co/Qc5Mcacu8a
02. Avances en Sarcoidosis: https://t.co/otf8ytgMrH
#EULAR2022
What is New (WIN)
Osteoarthritis – evolving treatments
This talk is a must-watch on-demand - highly recommended
🗝Proposed NICE-UK guidelines for
⭐️ NEFRITIS LÚPICA (review) 🦋:
📍Clasificación
📍Criterios de biopsia renal y de rebiopsia
📍 Pruebas complementarias
💊 Tratamiento
🆕 Novedades nefritis lúpica III y IV
An erosive hand osteoarthritis (EOA) study from the Osteoarthritis Initiative shows that EOA is more common in older women and is strongly linked to further progressive, articular structural damage.
https://t.co/XOVKNj423l
Textbooks say fever is common in lupus ("36%–86%") BUT IT IS NOT! Lupus is cause of FUO in 5%; Fever is seen in a minority of SLE onsets; Fever occurs w/ SLE complications - vasculitis, pneumonitis/serositis/alveolar hem, CNS, & INFECTION! https://t.co/KvZeo6Q1WY
Nos alegra presentar una solidaria iniciativa originada por algunos médicos reumatólogos del norte de Chile. El Dr. Cristian Zenteno voluntario en Arica nos da su visión al respecto. ¡Nuestras Felicitaciones!.
Entrevista: https://t.co/v2FS0FymTG
India gave approval to the Oxford-AstraZeneca vaccine, as well as a local version, for emergency use in a promising move for the developing world. https://t.co/ZuODI4TkU2
NEW ACR2020 Draft Guidelines for the Pharmacologic Treatment of RA
All the guidelines in 2 tables!
1. MTX 1st, oral > SC
2. Minimize GC!
3. TTT TTT TTT
4. Biologic/tsDMARD > Triple Tx
5. Taper MTX 1st
Close to my practice; suspect will be controversial!
#ACR20#ACRambassador